JCI - Citations to Developing aptamers into therapeutics

Citations to this article

Developing aptamers into therapeutics

Rebekah R. White, … , Bruce A. Sullenger, Christopher P. Rusconi

Rebekah R. White, … , Bruce A. Sullenger, Christopher P. Rusconi

Published October 15, 2000
Citation Information: J Clin Invest. 2000;106(8):929-934. https://doi.org/10.1172/JCI11325.

View: Text | PDF

Total citations by year

Year:	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	Total
Citations:	2	2	3	7	3	4	1	4	4	7	10	3	4	6	6	4	5	3	4	4	1	2	2	3	1	3	98

Citation information

Citations to this article (98)

Title and authors	Publication	Year
Using aptamers for targeted delivery of RNA therapies Driscoll J, Gondaliya P, Zinn DA, Jain R, Yan IK, Dong H, Patel T	Molecular Therapy	2025
DNA aptamer-polymer conjugates for selective targeting of integrin α4β1+ T-lineage cancers Cardle II, Raman J, Nguyen DC, Wang T, Wu AY, Sellers DL, Pichon TJ, Cheng EL, Kacherovsky N, Salipante SJ, Jensen MC, Pun SH	ACS applied materials & interfaces	2025
Therapeutic Applications of Aptamers Santarpia G, Carnes E	International journal of molecular sciences	2024
DNA-controlled protein fluorescence: Design of aptamer-split peptide hetero-modulator for GFP to respond to intracellular ATP levels Park KS, Cha H, Niu J, Soh HT, Lee JH, Pack SP	Nucleic Acids Research	2024
Aptamer-based rapid diagnosis for point-of-care application Futane A, Narayanamurthy V, Jadhav P, Srinivasan A	Microfluidics and Nanofluidics	2023
Cell Surface Labeling and Detection of Protein Tyrosine Kinase 7 via Covalent Aptamers Albright S, Cacace M, Tivon Y, Deiters A	Journal of the American Chemical Society	2023
Towards better antivenoms: navigating the road to new types of snakebite envenoming therapies. Thumtecho S, Burlet NJ, Ljungars A, Laustsen AH		2023
First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers Hernández-Jiménez M, Martín-Vílchez S, Ochoa D, Mejía-Abril G, Román M, Camargo-Mamani P, Luquero-Bueno S, Jilma B, Moro MA, Fernández G, Piñeiro D, Ribó M, González VM, Lizasoain I, Abad-Santos F		2022
Optimization of Short RNA Aptamers for TNBC Cell Targeting. Camorani S, d'Argenio A, Agnello L, Nilo R, Zannetti A, Ibarra LE, Fedele M, Cerchia L	International journal of molecular sciences	2022
Small Drugs, Huge Impact: The Extraordinary Impact of Antisense Oligonucleotides in Research and Drug Development Quemener AM, Centomo ML, Sax SL, Panella R	Molecules (Basel, Switzerland)	2022
Construction of a redox-responsive drug delivery system utilizing the volume of AS1411 spatial configuration gating mesoporous silica pores. Zhou L, Zhang Y, Ma Y		2022
Therapeutic Potential of Aptamer–Protein Interactions Shraim AS, Abdel Majeed BA, Al-Binni MA, Hunaiti A		2022
Factor XI/XIa Inhibition: The Arsenal in Development for a New Therapeutic Target in Cardio- and Cerebrovascular Disease Badimon JJ, Escolar G, Zafar MU	Journal of Cardiovascular Development and Disease	2022
Protein labeling and crosslinking by covalent aptamers. Cacace M, Tivon Y, Deiters A	Methods in enzymology	2022
Aptamer Detection of Mycobaterium tuberculosis Mannose-Capped Lipoarabinomannan in Lesion Tissues for Tuberculosis Diagnosis Y Zhou, H Xiong, R Chen, L Wan, Y Kong, J Rao, Y Xie, C Huang, XL Zhang	Frontiers in Cellular and Infection Microbiology	2021
Recent Advancements in Aptamer-Based Surface Plasmon Resonance Biosensing Strategies CC Chang	Biosensors	2021
Protein Labeling and Crosslinking by Covalent Aptamers Y Tivon, G Falcone, A Deiters	Angewandte Chemie (International ed. in English)	2021
Advances in oligonucleotide drug delivery TC Roberts, R Langer, MJ Wood	Nature Reviews Drug Discovery	2020
Therapeutic Application of Drug-Conjugated HER2 Oligobody (HER2-DOligobody) HJ Kim, HJ Sung, YM Lee, SI Choi, YH Kim, K Heo, IH Kim	International journal of molecular sciences	2020
Targeting TLR4 with ApTOLL Improves Heart Function in Response to Coronary Ischemia Reperfusion in Pigs Undergoing Acute Myocardial Infarction R Ramirez-Carracedo, L Tesoro, I Hernandez, J Diez-Mata, D Piñeiro, M Hernandez-Jimenez, JL Zamorano, C Zaragoza	Biomolecules	2020
Recent advances in understanding oligonucleotide aptamers and their applications as therapeutic agents KS Allemailem, A Almatroudi, MA Alsahli, GT Basfar, F Alrumaihi, AH Rahmani, AA Khan	3 Biotech	2020
A Mini-Review: Clinical Development and Potential of Aptamers for Thrombotic Events Treatment and Monitoring AT Ponce, KL Hong	Biomedicines	2019
TLR4-Binding DNA Aptamers Show a Protective Effect against Acute Stroke in Animal Models G Fernández, A Moraga, MI Cuartero, A García-Culebras, C Peña-Martínez, JM Pradillo, M Hernández-Jiménez, S Sacristán, MI Ayuso, R Gonzalo-Gobernado, D Fernández-López, ME Martín, MA Moro, VM González, I Lizasoain	Molecular Therapy	2018
A Synthetic Cross-Species CD200R1 Agonist Suppresses Inflammatory Immune Responses In Vivo A Prodeus, A Sparkes, NW Fischer, M Cydzik, E Huang, I Khatri, A Young, L Woo, CW Chow, R Gorczynski, J Gariépy	Molecular Therapy — Nucleic Acids	2018
Selection and Identification of Skeletal-Muscle-Targeted RNA Aptamers S Philippou, NP Mastroyiannopoulos, N Makrides, CW Lederer, M Kleanthous, LA Phylactou	Molecular Therapy — Nucleic Acids	2018
Dimerization of an aptamer generated from Ligand-guided selection (LIGS) yields a high affinity scaffold against B-cells S Batool, KV Argyropoulos, R Azad, P Okeoma, H Zumrut, S Bhandari, R Dekhang, PR Mallikaratchy	Biochimica et Biophysica Acta (BBA) - General Subjects	2018
Evolution of Complex Target SELEX to Identify Aptamers against Mammalian Cell-Surface Antigens P Mallikaratchy	Molecules (Basel, Switzerland)	2017
Effect of Chemical Modifications on Aptamer Stability in Serum C Kratschmer, M Levy	Nucleic Acid Therapeutics (Formerly Oligonucleotides)	2017
Discovery of Aptamer Ligands for Hepatic Stellate Cells Using SELEX Z Chen, H Liu, A Jain, L Zhang, C Liu, K Cheng	Theranostics	2017
Anti-angiogenesis target therapy for advanced osteosarcoma (Review) L Xie, T Ji, W Guo	Oncology reports	2017
Design of Potent and Controllable Anticoagulants Using DNA Aptamers and Nanostructures A Rangnekar, JA Nash, B Goodfred, YG Yingling, TH LaBean	Molecules (Basel, Switzerland)	2016
Selection and Biosensor Application of Aptamers for Small Molecules F Pfeiffer, G Mayer	Frontiers in Chemistry	2016
Characterization of MNK1b DNA Aptamers That Inhibit Proliferation in MDA-MB231 Breast Cancer Cells EM García-Recio, C Pinto-Díez, MI Pérez-Morgado, M García-Hernández, G Fernández, ME Martín, VM González	Molecular Therapy — Nucleic Acids	2016
Ligand-Guided Selection of Target-Specific Aptamers: A Screening Technology for Identifying Specific Aptamers Against Cell-Surface Proteins HE Zumrut, MN Ara, M Fraile, G Maio, P Mallikaratchy	Nucleic Acid Therapeutics (Formerly Oligonucleotides)	2016
Isolation of an Aptamer that Binds Specifically to E. coli S Marton, F Cleto, MA Krieger, J Cardoso, H Ulrich	PloS one	2016
Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses V González, M Martín, G Fernández, A García-Sacristán	Pharmaceuticals (Basel, Switzerland)	2016
Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes Y Patil-Sen, A Sadeghpour, M Rappolt, CV Kulkarni	Journal of visualized experiments : JoVE	2016
Nucleic Acid Aptamer-Guided Cancer Therapeutics and Diagnostics: the Next Generation of Cancer Medicine D Xiang, S Shigdar, G Qiao, T Wang, AZ Kouzani, SF Zhou, L Kong, Y Li, C Pu, W Duan	Theranostics	2015
Highly stable aptamers selected from a 2′-fully modified fGmH RNA library for targeting biomaterials AD Friedman, D Kim, R Liu	Biomaterials	2015
Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challenges AF Sikorski, M Toporkiewicz, J Meissner, L Matusewicz, A Czogalla	International Journal of Nanomedicine	2015
In Vitro Selection of Single-Stranded DNA Molecular Recognition Elements against S. aureus Alpha Toxin and Sensitive Detection in Human Serum K Hong, L Battistella, A Salva, R Williams, L Sooter	International journal of molecular sciences	2015
Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers A Prodeus, A Abdul-Wahid, NW Fischer, EH Huang, M Cydzik, J Gariépy	Molecular Therapy — Nucleic Acids	2015
DNA Aptamer Assembly as a Vascular Endothelial Growth Factor Receptor Agonist V Ramaswamy, A Monsalve, L Sautina, MS Segal, J Dobson, JB Allen	Nucleic Acid Therapeutics (Formerly Oligonucleotides)	2015
Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors D Xiang, C Zheng, SF Zhou, S Qiao, PH Tran, C Pu, Y Li, L Kong, AZ Kouzani, J Lin, K Liu, L Li, S Shigdar, W Duan	Theranostics	2015
Molecular and Functional Characterization of ssDNA Aptamers that Specifically Bind Leishmania infantum PABP N Guerra-Pérez, E Ramos, M García-Hernández, C Pinto, M Soto, ME Martín, VM González, HD Schallig	PloS one	2015
Anti-transcription Factor RNA Aptamers as Potential Therapeutics E Mondragón, LJ Maher	Nucleic Acid Therapeutics (Formerly Oligonucleotides)	2015
Selection of Single-Stranded DNA Molecular Recognition Elements against Exotoxin A Using a Novel Decoy-SELEX Method and Sensitive Detection of Exotoxin A in Human Serum KL Hong, K Yancey, L Battistella, RM Williams, KM Hickey, CD Bostick, PM Gannett, LJ Sooter	BioMed Research International	2015
Agonistic CD200R1 DNA Aptamers Are Potent Immunosuppressants That Prolong Allogeneic Skin Graft Survival A Prodeus, M Cydzik, A Abdul-Wahid, E Huang, I Khatri, R Gorczynski, J Gariépy	Molecular Therapy — Nucleic Acids	2014
Aptamer photoregulation in vivo L Li, R Tong, H Chu, W Wang, R Langer, DS Kohane	Proceedings of the National Academy of Sciences	2014
Aptamer technology for tracking cells’ status & function C Wiraja, D Yeo, D Lio, L Labanieh, M Lu, W Zhao, C Xu	Molecular and Cellular Therapies	2014
Integration of drug, protein, and gene delivery systems with regenerative medicine ER Lorden, HM Levinson, KW Leong	Drug Delivery and Translational Research	2013
Development of an antigen-DNAzyme based probe for a direct antibody-antigen assay using the intrinsic DNAzyme activity of a daunomycin aptamer N Omar, Q Loh, GJ Tye, YS Choong, R Noordin, J Glökler, TS Lim	Sensors (Basel, Switzerland)	2013
DNA aptamers selectively target Leishmania infantum H2A protein ME Martín, M García-Hernández, EM García-Recio, GF Gómez-Chacón, M Sánchez-López, VM González	PloS one	2013
Aptamers as theranostic agents: modifications, serum stability and functionalisation S Shigdar, J Macdonald, M O'Connor, T Wang, D Xiang, HA Shamaileh, L Qiao, M Wei, SF Zhou, Y Zhu, L Kong, S Bhattacharya, CG Li, W Duan	Sensors (Basel, Switzerland)	2013
Aptamer-conjugated polymeric nanoparticles for targeted cancer therapy A Aravind, Y Yoshida, T Maekawa, DS Kumar	Drug Delivery and Translational Research	2012
Aptamer base: a collaborative knowledge base to describe aptamers and SELEX experiments J Cruz-Toledo, M McKeague, X Zhang, A Giamberardino, E McConnell, T Francis, MC DeRosa, M Dumontier	Database	2012
Ipilimumab Pharmacotherapy in Patients with Metastatic Melanoma JM Jeter, LD Cranmer, EM Hersh	Clinical Medicine Insights. Oncology	2012
Aptamers and the next generation of diagnostic reagents V Thiviyanathan, DG Gorenstein	PROTEOMICS - CLINICAL APPLICATIONS	2012
New treatments in hemophilia: insights for the clinician K Knobe, E Berntorp	Therapeutic Advances in Hematology	2012
Capture, isolation and release of cancer cells with aptamer-functionalized glass bead array Y Wan, Y Liu, PB Allen, W Asghar, MA Mahmood, J Tan, H Duhon, Y Kim, AD Ellington, SM Iqbal	Lab on a Chip	2012
Inhibition of cell proliferation by an anti-EGFR aptamer N Li, HH Nguyen, M Byrom, AD Ellington	PloS one	2011
An RNA aptamer perturbs heat shock transcription factor activity in Drosophila melanogaster HH Salamanca, N Fuda, H Shi, JT Lis	Nucleic Acids Research	2011
Aptamers can Discriminate Alkaline Proteins with High Specificity H Yu, B Jiang, JC Chaput	ChemBioChem	2011
Bi-specific Aptamers Mediating Tumor Cell Lysis A Boltz, B Piater, L Toleikis, R Guenther, H Kolmar, B Hock	The Journal of biological chemistry	2011
Selection and analytical applications of aptamers binding microbial pathogens CL Hamula, H Zhang, F Li, Z Wang, XC Le, XF Li	Trends in analytical chemistry : TRAC	2011
Aptamers as Therapeutics in Cardiovascular Diseases Wang P, Yang Y, Hong H, Zhang Y, Cai W, Fang D	Current medicinal chemistry	2011
Molecular recognition elements: DNA/RNA-aptamers to proteins VA Spiridonova	Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry	2010
Aptamers for Targeted Drug Delivery P Ray, RR White	Pharmaceuticals (Basel, Switzerland)	2010
Strategies for the discovery of therapeutic aptamers X Yang, N Li, DG Gorenstein	Expert Opinion on Drug Discovery	2010
Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy. Niu G, Chen X	Current drug targets	2010
Pulmonary surfactant: an immunological perspective ZC Chroneos, Z Sever-Chroneos, VL Shepherd	Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology	2009
Characterization of RNA aptamers that disrupt the RUNX1–CBFβ/DNA complex JL Barton, DH Bunka, SE Knowling, P Lefevre, AJ Warren, C Bonifer, PG Stockley	Nucleic Acids Research	2009
Crystallization and preliminary X-ray diffraction data of an LNA 7-mer duplex derived from a ricin aptamer C Förster, D Oberthuer, J Gao, A Eichert, FG Quast, C Betzel, A Nitsche, VA Erdmann, JP Fürste	Acta Crystallographica Section F Structural Biology and Crystallization Communications	2009
Capturing Single Molecules of Immunoglobulin and Ricin with an Aptamer-Encoded Glass Nanopore S Ding, C Gao, LQ Gu	Analytical Chemistry	2009
Aptamer-Encoded Nanopore for Ultrasensitive Detection of Bioterrorist Agent Ricin at Single-Molecule Resolution Gu LQ, Ding S, Gao C	Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference	2009
A nuclease-resistant RNA aptamer specifically inhibits angiopoietin-1-mediated Tie2 activation and function RR White, JA Roy, KD Viles, BA Sullenger, CD Kontos	Angiogenesis	2008
TFIIB aptamers inhibit transcription by perturbing PIC formation at distinct stages A Sevilimedu, H Shi, JT Lis	Nucleic Acids Research	2008
Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy R Simó, C Hernández	Diabetologia	2008
Costimulation of CD8+ T cells and inhibition of tumor growth with multivalent 4-1BB binding aptamers James O. McNamara II Despina Kolonias Fernando Pastor Robert S. Mittler Lieping Chen Paloma H. Giangrande Bruce Sullenger Eli Gilboa	Journal of Clinical Investigation	2007
G-quadruplex induced stabilization by 2'-deoxy-2'-fluoro-D-arabinonucleic acids (2'F-ANA) CG Peng, MJ Damha	Nucleic Acids Research	2007
Selection of DNA aptamers against DC-SIGN protein Y Hui, L Shan, Z Lin-fu, Z Jian-hua	Molecular and Cellular Biochemistry	2007
Production and Characterization of RNA Aptamers Specific for Amyloid Fibril Epitopes DH Bunka, BJ Mantle, IJ Morten, GA Tennent, SE Radford, PG Stockley	The Journal of biological chemistry	2007
Drug delivery systems in urology--getting "smarter" OC Farokhzad, JD Dimitrakov, JM Karp, A Khademhosseini, MR Freeman, R Langer	Urology	2006
High-affinity aptamers to subtype 3a hepatitis C virus polymerase display genotypic specificity LA Jones, LE Clancy, WD Rawlinson, PA White	Antimicrobial agents and chemotherapy	2006
Comparative crystallization and preliminary X-ray diffraction studies of locked nucleic acid and RNA stems of a tenascin C-binding aptamer C Förster, AB Brauer, S Brode, KS Schmidt, M Perbandt, A Meyer, W Rypniewski, C Betzel, J Kurreck, JP Fürste, VA Erdmann	Acta crystallographica. Section F, Structural biology and crystallization communications	2006
RiboaptDB: A Comprehensive Database of Ribozymes and Aptamers V Thodima, M Pirooznia, Y Deng	BMC bioinformatics	2006
Hepatic Tumor Growth: Target for Angiogenesis Inhibition? S Sarraf-Yazdi, J Mi, BM Clary	World Journal of Surgery	2005
Application of locked nucleic acids to improve aptamer in vivo stability and targeting function KS Schmidt, S Borkowski, J Kurreck, AW Stephens, R Bald, M Hecht, M Friebe, L Dinkelborg, VA Erdmann	Nucleic Acids Research	2004
Protein-Binding Oligonucleotides: The Next Frontier in Antithrombotic Therapy RC Becker	Journal of Thrombosis and Thrombolysis	2004
In vivo imaging with oligonucleotides for diagnosis and drug development B Tavitian	Gut	2003
Short bioactive Spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: tailored-SELEX A Vater, F Jarosch, K Buchner, S Klussmann	Nucleic Acids Research	2003
Targeting a KH-domain protein with RNA decoys. Makeyev AV, Eastmond DL, Liebhaber SA	RNA (New York, N.Y.)	2002
Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1 Chaloin L, Lehmann MJ, Sczakiel G, Restle T	Nucleic Acids Research	2002
Is antisense an appropriate nomenclature or design for oligodeoxynucleotides aimed at the inhibition of HIV-1 replication? Lavigne C, Yelle J, Sauve G, Thierry AR	AAPS PharmSci	2002
Lipid-based delivery of combinations of antisense oligodeoxynucleotides for the in vitro inhibition of HIV-1 replication C Lavigne, J Yelle, G Sauvé, AG Thierry	AAPS PharmSci	2001
Escort Aptamers: a delivery service for diagnosis and therapy Brian Hicke, Andrew W. Stephens	Journal of Clinical Investigation	2000
Therapeutic applications of transcription factor decoy oligonucleotides Michael J. Mann, Victor J. Dzau	Journal of Clinical Investigation	2000
Catalytic DNAs as Potential Therapeutic Agents and Sequence-Specific Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function Levon Khachigian	Journal of Clinical Investigation	2000

Advertisement